Manage risks during pharmaceutical transport
Biodegradable, low emissions and odourless
Maintaining the quality and integrity of medical and biological products during transport is critical for pharmaceutical manufacturers and logistics providers for public health and patient safety.
As most medical and biological products require a temperature controlled environment at all stages of manufacturing and distribution, the control of storage and transportation temperatures is vital in maintaining the quality and effectiveness of medicines.
25%
… of vaccines reach their destination in a degraded state because of incorrect shipping.
30%
… of scrapped sales at pharmaceutical companies can be attributed to logistics issues.
20%
… of temperature-sensitive health care products are damaged during transport due to a broken cold chain.
0.5%
… of transported goods are damaged during transport through non-compliance to temperature guidelines.
What is Good Distribution Practice (GDP) for pharmaceutical products?
The objective of Good Distribution Practice (GDP) guidelines is to ensure that the high level of product quality, determined by good manufacturing practices, is maintained throughout the distribution chain. This extends beyond the transport vehicles used to take pharmaceuticals (such as APIs) and medical components from the manufacturing facility to distributors and wholesalers. It must also ensure compliant delivery to hospitals and pharmacies.
It is mandatory for distributors to comply with the European Union guidelines on good distribution practice of medicinal products for human use.
Resources
Discover more about the range of TK PharmaSolutions available for optimizing frozen medicine storage, vaccine distribution, health care product delivery, and refrigerated transport. Access details on our GDP-qualified pharmaceutical products, and gain a fuller picture of how we can help boost your performance and profitability.
